Risk factors for stroke in type 2 diabetes mellitus

Diabetes and Vascular Disease Research

Volumn 3, Issue 1, 2006, Pages 57-60

  Asfandiyarova, Nailya ^a   Kolcheva, Nina ^a   Ryazantsev, Igor ^a   Ryazantsev, Vladimir ^a  

^a Central District Hospital   (Russian Federation)

Author keywords

Cell mediated immunity; Histamine; Insulin; Prostaglandin; Risk factors; Stroke; Type 2 diabetes mellitus

Indexed keywords

CIMETIDINE; INDOMETACIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNITY, CELLULAR; INSULIN; MALE; MIDDLE AGED; PROSTAGLANDINS; RECEPTORS, HISTAMINE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33745048033     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2006.009     Document Type: Article

References (34)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
2. Ellekjear EF, Wyller TB, Sverre JM, Holmen J. Lifestyle factors and risk of cerebral infarction. Stroke 1992;23:829-34.
3. Kagan A, Popper JS, Rhoads GG, Yano K. Dietary and other risk factors for stroke in a cohort of men born in 1913. N Engl J Med 1987;317: 521-6.
4. Abbott RD, Donahue RO, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke JAMA 1987;257:949-52.
5. Barrettt-Connor E, Khaw KT. Diabetes mellitus: an independent risk for stroke? Am J Epidemiol 1988;128:116-23.
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-44.
7. Folsom AR, Rasmussen ML, Chambless LE et al. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care 1999;22:1077-83.
8. Kothari V, Stevens RJ, Adler AI et al. Risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine (abstr). Stroke 2002;33:1776.
9. Hamidon BB, Raymond AA. The impact of diabetes mellitus on in-hospital stroke mortality. JPCM 2003;49:307-10.
10. Cray CS, Scott JF, French JM, Alberti KGMM, O'Connell JE. Prevalence and prediction of unrecognized diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing 2004;33:71 -7.
11. Mankovsky BN, Ziegler D. Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 2004;20:268-87.
12. Asfandiyarova NS, Kolcheva NG, Shatrova IV. About heterogeneity of diabetes mellitus (in Russian). Ter Arch 1999;12:49-52.
13. Coodwin JS, Bankhurst AD, Messner RR Suppression of human T-cell mitogenesis by prostaglandin. J Exp Med 1977;146:1719-34.
14. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology. The essentials. 3rd edition. London: Williams & Wilkins, 1996.
15. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke 1994;25:1977-84.
16. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001;58:1209-12.
17. Stevens RJ, Coleman RL, Adler Al, Stratton IM, Matthews DR, Holman RR. Risk factors for myocardial infarction, case fatality and stroke case fatality in type 2 diabetes. UKPDS 66. Diabetes Care 2004;27:201-07.
18. Tuomolehto J, Rastenyt D, Jousilahti P, Satti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke. Sirote 1996;27:210-15.
19. Di Bonito P, Di Fraia L, Di Gennaro L et al. Impact of known and unknown diabetes on in hospital mortality from ischemic stroke. Nutr Metabol Cardiovasc Dis 2003;13:148-53.
20. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 2004; 21:252-5.
21. Shinozaki K, Naritomi H, Shimizu T et al. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 1996;27:37-43.
22. Matsumoto R, Miyake S, Yano M et al. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic: stroke. Diabetes Care 1999;22:1191-5.
23. Pyörälä M, Miettinen H, Halonen P, Laakso M, Pyörälä K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men (abstract). Arterioscl Thromb Vasc Biol 2000;20:538.
24. Asfandiyarova NS. Indomethacin and ranitidin in the treatment of insulin resistance (abstr). Diabetes Vasc Dis Res 2004;1:138.
25. Newman WP, Brodows RG. Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metabol 1983;57:1102-06.
26. Kim JK, Kim Y-J, Fillmore JJ et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001;108:437-46.
27. Netea MG, Tack CJ, Netten PM, Lutterman JA, Van Der Meer JWM. The effect of salicylates on insulin sensitivity. J Clin Invest 2001;108: 1723-4.
28. Kim JK, Shoelson SE, Shulman GI. Response: The effect of salicylates on insulin sensitivity. J Clin Invest 2001;108:1724.
29. Hundal RS, Petersen KF, Mayerson AB. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002;109:1321-6.
30. Zeender E, Maedler K, Bosco D, Berney T, Donath MY, Halban PA. Pioglitazone and sodium salicylate protect human B-cells against apoptosis and impaired function induced by glucose and interleukin-1B. J Clin Endocrinol Metabol 2004;89:5059-66.
31. Asfandiyarova NS, Shatrov VV, Goncharenko LV, Kolcheva NG. Immune system in elderly and old persons (in Russian). Klin Gerontol 1996;4:25-8.
32. Asfandiyarova NS, Ryazantsev IV, Ryazantsev VS. Cell-mediated immunity against insulin in stroke (in Russian). Zurnal neuropathol psyhiatr (suppl Stroke) 2004;12:66-71.
33. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-23.
34. Sjoholm A, Nystrom T. Endothelial inflammation in insulin resistance. Lancet 2005;12(365):610-12.